Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;17(3):812-20.
doi: 10.1245/s10434-009-0827-4.

A critical appraisal of circumferential resection margins in esophageal carcinoma

Affiliations

A critical appraisal of circumferential resection margins in esophageal carcinoma

Bareld B Pultrum et al. Ann Surg Oncol. 2010 Mar.

Abstract

Background: In esophageal cancer, circumferential resection margins (CRMs) are considered to be of relevant prognostic value, but a reliable definition of tumor-free CRM is still unclear. The aim of this study was to appraise the clinical prognostic value of microscopic CRM involvement and to determine the optimal limit of CRM.

Methods: To define the optimal tumor-free CRM we included 98 consecutive patients who underwent extended esophagectomy with microscopic tumor-free resection margins (R0) between 1997 and 2006. CRMs were measured in tenths of millimeters with inked lateral margins. Outcome of patients with CRM involvement was compared with a statistically comparable control group of 21 patients with microscopic positive resection margins (R1).

Results: A cutoff point of CRM at < or = 1.0 mm and > 1.0 mm appeared to be an adequate marker for survival and prognosis (both P < 0.001). The outcome in patients with CRMs < or = 1.0 and > 0 mm was equal to that in patients with CRM of 0 mm (P = 0.43). CRM involvement was an independent prognostic factor for both recurrent disease (P = 0.001) and survival (P < 0.001). Survival of patients with positive CRMs (< or = 1 mm) did not significantly differ from patients with an R1 resection (P = 0.12).

Conclusion: Involvement of the circumferential resection margins is an independent prognostic factor for recurrent disease and survival in esophageal cancer. The optimal limit for a positive CRM is < or = 1 mm and for a free CRM is >1.0 mm. Patients with unfavorable CRM should be approached as patients with R1 resection with corresponding outcome.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
a Cross-sections of a specimen through the tumor with 0.5-cm-wide slices. b Cross-section with macroscopically minimal distance between the tumor and the nearest inked margin
Fig. 2
Fig. 2
Microscopic example of CRM measurement, from most lateral tumor cells to the inked outer margins; an enlargement of the margin is shown in the inset
Fig. 3
Fig. 3
Schematic representation of four possible microscopic circumferential resection margins (CRM) measurements in different esophageal cross-sections: a tumor with free CRM, measurement performed in tenths of millimeters; b small tumor with narrow free CRM, damage to the esophageal wall caused by surgical manipulation; c large tumor, directly growing into the CRM; d tumor with satellite (spray) growth into the CRM with few malignant cells
Fig. 4
Fig. 4
Cancer-specific survival by CRM in three categories: CRMs with tumor ingrowth (0 mm) had similar outcome to CRMs ≤1 mm and >0 mm (P = 0.43); both had significantly worse outcome compared with CRM >1 mm (P < 0.001 and P = 0.004, respectively)
Fig. 5
Fig. 5
Equal cancer-specific survival of positive CRMs and R1 resections. Kaplan–Meier survival curve of patients with positive resection margins (R1) of the control group (n = 21) and patients of the study group with positive CRM ≤1 mm (CRM+) (n = 51, 52%) and free CRM >1 mm (CRM−) (n = 47, 48%). There was no significant difference in survival between CRM+ and R1 (P = 0.12); significant differences were found between CRM− with CRM+ and R1 (both P < 0.001)

References

    1. Powell J. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer. 2002;102:422–427. doi: 10.1002/ijc.10721. - DOI - PubMed
    1. Plukker JT, van Westreenen HL. Staging in oesophageal cancer. Best Pract Res Clin Gastroenterol. 2006;20:877–891. doi: 10.1016/j.bpg.2006.05.001. - DOI - PubMed
    1. Lerut T, Coosemans W, De Leyn P, Decker G, Deneffe G, Van Raemdonck D. Is there a role for radical esophagectomy. Eur J Cardiothorac Surg. 1999;16(Suppl 1):S44–S47. doi: 10.1016/S1010-7940(99)00185-2. - DOI - PubMed
    1. Shao LF, Gao ZG, Yang NP, Wei GQ, Wang YD, Cheng CP. Results of surgical treatment in 6, 123 cases of carcinoma of the esophagus and gastric cardia. J Surg Oncol. 1989;42:170–174. doi: 10.1002/jso.2930420308. - DOI - PubMed
    1. Mulligan ED, Dunne B, Griffin M, Keeling N, Reynolds JV. Margin involvement and outcome in oesophageal carcinoma: a 10-year experience in a specialist unit. Eur J Surg Oncol. 2004;30:313–317. doi: 10.1016/j.ejso.2003.11.009. - DOI - PubMed